

Broncus Holding Company, a provider of diagnostic and therapeutic technology for lung diseases, has raised an undisclosed amount of Series C funding. Lake Bleu Capital led the round with participation from other investors that included Baidu Capital, Ascendum Capital, CNCB Capital, DCP Capital and Qiming Venture Capital.
Source: Press Release